Chapter 31 : Measles, Mumps, and Rubella

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in

Measles, Mumps, and Rubella, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815974/9781555814625_Chap31-1.gif /docserver/preview/fulltext/10.1128/9781555815974/9781555814625_Chap31-2.gif


The nucleoprotein, phosphoprotein, and large polymerase protein, in conjunction with the virion negative-strand RNA, comprise the ribonucleoprotein complex, the replicating and transcriptional unit of measles virus. Traditional antibody tests such as hemagglutination inhibition (HI), plaque reduction neutralization test (PRNT), and enzyme immunoassay (EIA) have been used extensively in the serologic diagnosis of measles. However, because of the availability of sensitive and specific commercial kits, EIAs have become the most widely used test format. The mumps genome is encapsidated by nucleoprotein, and as in the case of measles virus, the phosphoprotein and polymerase are associated with the encapsidated RNA to comprise the ribonucleoprotein complex. Enzyme-linked immunosorbent assay vary greatly in sensitivity (range, 24 to 51%), and the best specificity measured was 82%. Of considerable interest is the use of oral fluid rather than serum in the determination of Immunoglobulin M (IgM) for acute mumps infections and IgG for immune status for measles, mumps, and rubella. Rubella would be of little medical importance were it not for the profound defects rubella virus (RV) infection can cause in the unborn child. Mumps vaccine is given along with measles and rubella vaccines at 12 to 15 months of age and again at school entry. Laboratory diagnosis of both postnatal and congenital RV infections is by serologic and/or virus detection techniques.

Citation: Bellini W, Icenogle J, Sever J. 2009. Measles, Mumps, and Rubella, p 562-577. In Specter S, Hodinka R, Young S, Wiedbrauk D (ed), Clinical Virology Manual, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815974.ch31
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Albrecht, P.,, K. Herrmann, and, G. R. Burns. 1981. Role of virus strain in conventional and enhanced measles plaque neutralization test. J. Virol. Methods 3:251260.
2. American Academy of Pediatrics. 1997. Measles, p. 344–357. In G. Peters (ed.), Red Book: Report of the Committee on Infectious Diseases, 24th ed. American Academy of Pediatrics, Elk Grove, IL.
3. Arista, S.,, D. Ferraro,, A. Cascio,, E. Vizzi, and, R. di Stefano. 1995. Detection of IgM antibodies specific for measles virus by capture and indirect enzyme immunoassays. Res. Virol. 146:225232.
4. Atkinson, W. L.,, and W. A. Orenstein. 1992. The resurgence of measles in the United States, 1989-1990. Annu. Rev. Med. 43:451463.
5. Badilla, X.,, A. Morice,, M. L. Avila-Aguero,, E. Saenz,, I. Cerda,, S. Reef, and, C. Castillo-Solórzano. 2007. Fetal risk associated with rubella vaccination during pregnancy. Pediatr. Infect. Dis. J. 26:830835.
6. Banatvala, J. E.,, and J. M. Best. 1998. Rubella, p. 551–577. In L. Collier,, A. Balows, and, M. Sussman (ed.), Topley and Wilson’s Microbiology and Microbial Infections, 9th ed. Oxford University Press, New York, NY.
7. Bellini, W. J.,, and P. A. Rota. 1998. Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerg. Infect. Dis. 4:17.
8. Bellini, W. J.,, J. S. Rota,, L. E. Lowe,, R. S. Katz,, P. R. Dyken,, S. R. Zaki,, W.-J. Shieh, and, P. A. Rota. 2005. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than previously recognized. J. Infect. Dis. 192:16861693.
9. Bellini, W. J.,, and J. P. Icenogle. 2007. Measles and rubella viruses, p. 1378–1391. In P. R. Murray,, E. J. Baron,, J. H. Jorgensen,, M. L. Landry and, M. A. Pfaller (ed.), Manual of Clinical Microbiology, 9th ed. ASM Press, Washington, DC.
10. Berbers, G. A. M.,, A. H. J. O. Marzec,, M. Bastmeijer,, P. G. M. van Gageldonk, and, A. D. Plantinga. 1993. Blocking ELISA for detection of mumps and antibodies in human sera. J. Virol. Methods 42:155168.
11. Best, J. M.,, C. Castillo-Solorzano,, J. S. Spika,, J. Icenogle,, J. W. Glasser,, N. J. Gay,, J. Andrus, and, A. M. Arvin. 2005. Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee on research related to measles and rubella vaccines and vaccination, June 2004. J. Infect. Dis. 192:18901897.
12. Bitsko, R. H.,, M. Cortese,, G. Dayan,, P. A. Rota,, L. Lowe,, S. C. Iversen, and, W. J. Bellini. 2008. Detection of RNA of mumps virus during an outbreak in a population with high two-dose MMR coverage. J. Clin. Microbiol. 46:11011103.
13. Bloch, A. B.,, W. A. Orenstein,, H. C. Stetler,, S. G. Wassilak,, R. W. Amler,, K. J. Bart,, C. D. Kirby, and, A. R. Hinman. 1985. Health impact of measles vaccination in the United States. Pediatrics 76:52432.
14. Boddicker, J.,, P. Rota,, T. Kreman,, A. Wangeman,, L. Lowe,, K. Hummel,, R. Thompson,, W. Bellini,, M. Pentella, and, L. DesJardin. 2007. Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens. J. Clin. Microbiol. 45:29022908.
15. Boger, W. P., III. 1980. Late ocular complications in congenital rubella syndrome. Opthalmology (Rochester) 87:12441252.
16. Boger, W. P., III. 1981. Spontaneous absorption of the lens in the congenital rubella syndrome. Am. J. Ophthalmol. 99:433434.
17. Boriskin, Y. S.,, J. C. Booth, and, A. Yamada. 1993. Rapid detection of mumps virus by the polymerase chain reaction. J. Virol. Methods 42:2332.
18. Briss, P. A.,, L. J. Fehrs,, R. A. Parker,, P. F. Wright,, E. C. Sannella,, R. H. Hutcheson, and, W. Schaffner. 1994. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J. Infect. Dis. 169:7782.
19. Buynak, E. B.,, and M. R. Hilleman. 1966. Live attenuated mumps virus vaccine. Proc. Soc. Exp. Biol. Med. 123:768775.
20. Campbell, H.,, N. Andrews,, K. E. Brown, and, E. Miller. 2007. Review of the effect of measles vaccination on the epidemiology of SSPE. Int. J. Epidemiol. 36:13341348.
21. Cantell, K. 1961. Mumps virus. Adv. Virus Res. 8:123164.
22. Castillo-Solórzano, C.,, and J. K. Andrus. 2004. Rubella elimination and improving health care for women. Emerg. Infect. Dis. 10:20172021.
23. Centers for Disease Control. 1982. Countdown toward the elimination of measles in the U.S. MMWR Morb. Mortal. Wkly. Rep. 31:447478.
24. Centers for Disease Control. 1989. Measles prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb. Mortal. Wkly. Rep. 38:117.
25. Centers for Disease Control and Prevention. 2001. Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Morb. Mortal. Wkly. Rep. 50:1117.
26. Centers for Disease Control and Prevention. 2002. Manual for the surveillance of vaccine-preventable diseases. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/vaccines/pubs/surv-manual/default.htm. Accessed February 2008.
27. Centers for Disease Control and Prevention. 2004. Epidemiology of measles—United States, 2001–2003. MMWR Morb. Mortal. Wkly. Rep. 54:175178.
28. Centers for Disease Control and Prevention. 2005. Progress toward elimination of measles and prevention of congenital rubella infection—European region, 1990–2004. MMWR Morb. Mortal. Wkly. Rep. 54:175178.
29. Centers for Disease Control and Prevention. 2006a. Mumps epidemic—Iowa. MMWR Morb. Mortal. Wkly. Rep. 55:366368.
30. Centers for Disease Control and Prevention. 2006b. Update: multistate outbreak of mumps—United States, January 1–May 2. MMWR Morb. Mortal. Wkly. Rep. 55:559563.
31. Centers for Disease Control and Prevention. 2006c. Brief report: update: mumps activity—United States, January 1–October 7, 2006. MMWR Morb. Mortal. Wkly. Rep. 55:11521153.
32. Centers for Disease Control and Prevention. 2007. Rubella, congenital syndrome. 2007 case definition. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/ncphi/disss/nndss/casedef/rubellasccurrent.htm. Accessed February 2008.
33. Centers for Disease Control and Prevention. 2008a. ACIP Recommendations. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/vaccines/pubs/ACIP-list.htm. Accessed February 2008.
34. Centers for Disease Control and Prevention. 2008b. Multi-state measles outbreak associated with an international youth sporting event—Pennsylvania, Michigan, and Texas, August–September, 2007. MMWR Morb. Mortal. Wkly. Rep. 57:169173.
35. Centers for Disease Control and Prevention. 2008c. Update: measles—United States, January–July 2008. MMWR Morb. Mortal. Wkly. Rep. 57:893896.
36. Chaiken, B. P.,, N. M. Williams,, S. R. Preblud,, W. Parkin, and, R. Altman. 1987. The effect of a school entry law on mumps activity in a school district. JAMA 257:24552458.
37. Chen, M.-H.,, and J. Icenogle. 2007. Molecular virology of rubella virus, p. 1–18. In J. Banatvala and, C. Peckham (ed), Rubella Viruses, Perspectives in Medical Virology. Elsevier, Amsterdam, The Netherlands.
38. Chen, M.-H.,, Z. Zhen,, Y. Zhang,, S. Favors,, W. Xu,, D. A. Featherstone, and, J. P. Icenogle. 2007. An indirect immunocolorimetric assay to detect rubella virus infected cells. J. Virol. Methods 146:414418.
39. Cohen, B. J.,, R. P. Parry,, D. Doblas,, D. Samuel,, L. Warrener,, N. Andrews, and, D. Brown. 2006. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay. J. Virol. Methods 131:209212.
40. Cohen, B. J.,, S. Audet,, N. Andrews,, J. Beeler, and WHO Working Group on Measles Plaque Reduction Neutralization Test. 2007. Plaque reduction neutralization test for measles antibodies: description of a standardized laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 26:5966.
41. Condorelli, F.,, and T. Ziegler. 1993. Dot immunoblotting for simultaneous detection of specific immunoglobulin G antibodies to measles virus, mumps virus, and rubella virus. J. Clin. Microbiol. 31:717719.
42. Cooper, L. Z. The history and medical consequences of rubella. 1985. Rev. Infect. Dis. 7(Suppl. 1):S2S10.
43. Crowley, B.,, and M. A. Afzal. 2002. Mumps virus reinfection—clinical findings and serological vagaries. Commun. Dis. Public Health 5:311313.
44. Cutts, F. T.,, S. E. Robertson,, J.-L. Diaz-Ortega, and, R. Samuel. 1997. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1: burden of disease from CRS. Bull. W. H. O. 75:5568.
45. Dayan, G. H.,, M. P. Quinlisk,, A. A. Parker,, A. E. Barskey,, M. L. Harris,, J. M. Hill Schwartz,, K. Hunt,, C. G. Finley,, D. P. Leschinsky,, A. L. O’Keefe,, J. Clayton,, L. K. Kightlinger,, E. G. Dietle,, J. Berg,, C. L. Kenyon,, S. T. Goldstein,, S. K. Stokley,, S. B. Redd,, P. A. Rota,, J. Rota,, D. Bi,, S. W. Roush,, C. B. Bridges,, T. A. Santibanez,, U. Parashar,, W. J. Bellini, and, J. F. Seward. 2008. Recent resurgence of mumps in the United States. N. Engl. J. Med. 358:15801589.
46. de Groot-Mijnes, J. D.,, L. de Visser,, A. Rothova,, M. Schuller,, A. M. van Loon, and, A. J. Weersink. 2006. Rubella virus is associated with fuchs heterochromic iridocyclitis. Am. J. Ophthalmol. 141:212214.
47. de Souza, V. A.,, C. S. Pannuti,, L. M. Sumita, and, H. F. de Andrade, Jr. 1997. Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines. J. Med. Virol. 52:275279.
48. Eberhart-Phillips, J. E.,, P. D. Frederick,, R. C. Baron, and, L. Mascola. 1993. Measles in pregnancy: a descriptive study of 58 cases. Obstet. Gynecol. 82:797801.
49. Edmonson, M.,, D. Addiss,, J. McPherson,, J. Berg,, S. Circo, and, J. Davis. 1990. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 163:24672471.
50. El Mubarak, H. S.,, R. L. De Swart,, A. D. Osterhaus, and, M. Schutten. 2005. Development of a semi-quantitative real-time RT-PCR for the detection of measles virus. J. Clin. Virol. 32:313317.
51. Enders, J. F.,, and T. C. Peebles. 1954. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc. Soc. Exp. Biol. Med. 86:277286.
52. Erdman D. D., L. J. Anderson,, D. R. Adams,, J. A. Stewart,, L. E. Markowitz, and, W. J. Bellini. 1991. Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J. Clin. Microbiol. 29:14661471.
53. Erdman, D. D.,, J. L. Heath,, J. C. Watson,, L. E. Markowitz, and, W. J. Bellini. 1993. Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J. Med. Virol. 41:4448.
54. Floret, D.,, D. Rosenberg,, G. N. Hage, and, P. Monnet. 1980. Case report: hyperthyroidism, diabetes mellitus and the congenital rubella syndrome. Acta Paediatr. Scand. 69:250261.
55. Fuccillo, D. A.,, and J. L. Sever. 1973. Viral teratology. Bacteriol. Rev. 37:1931.
56. Fuccillo, D.A.,, R. W. Steele,, S. A. Henson,, M. M. Vincent,, J. B. Hardy, and, J. A. Bellanti. 1974. Impaired cellular immunity to rubella virus in congenital rubella. Infect. Immun. 9:8184.
57. Fujino, M.,, N. Yoshida,, S. Yamaguchi,, N. Hosaka,, Y. Ota,, T. Notomi, and, T. Nakayama. 2005. A simple method for the detection of measles virus genome by loop-mediated isothermal amplification (LAMP). J. Med. Virol. 76:406413.
58. Fulginiti, V.A.,, J. J. Eller,, A. W. Downie, and, C. H. Kempe. 1967. Altered reactivity to measles virus. JAMA 202:10751080.
59. Galazka, A. M.,, S. E. Robertson, and, A. Kraigher. 1999. Mumps and mumps vaccine: a global review. Bull. W. H. O. 77:314.
60. Germann, D.,, M. Gorgievski,, A. Strohle, and, L. Matter. 1998. Detection of mumps virus in clinical specimens by rapid centrifugation culture and conventional tube cell culture. J. Virol. Methods 73:5964.
61. Gershon, A.,, and S. Krugman. 1979. Measles virus, p. 665–693. In E. H. Lennette and, N. J. Schmidt (ed.), Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections. American Public Health Association, Washington, DC.
62. Glikmann, G.,, M. Pedersen, and, C. H. Mordhurst. 1986. Detection of specific immunoglobulin M to mumps virus in serum and cerebrospinal fluid samples from patients with acute mumps infection, using an antibody-capture enzyme immunoassay. Acta Pathol. Microbiol. Immunol. Scand. Sect. C 94:145156.
63. Grayzel, A. I.,, and C. Beck. 1971. The growth of vaccine strain of rubella virus in cultured human synovial cells. Proc. Soc. Exp. Biol. Med. 136:496498.
64. Gregg, N. 1941. Congenital cataract following German measles in the mother. Trans. Ophthalmol. Soc. Aust. 3:3546.
65. Gut, J. P.,, C. Lablache,, S. Behr, and, A. Kirn. 1995. Symptomatic mumps virus reinfections. J. Med. Virol. 5:1723.
66. Habel, K. 1945. Cultivation of mumps virus in the developing chick embryo and its application to studies of immunity to mumps in man. Public Health Rep. 60:201212.
67. Halsey, N. A.,, J. F. Modlin,, J. T. Jabbour,, L. Dubey,, D. L. Eddins,, D. D. Ludwig. 1980. Risk factors in subacute sclerosing panencephalitis: a case-control study. Am. J. Epidemiol. 111:415424.
68. Harling, R.,, J. M. White,, M. E. Ramsay,, K. F. Macsween, and, C. van den Bosch. 2005. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 23:40704074.
69. Helfand, R. F.,, D. K. Kim. H. E. Gary,, G. L. Edwards,, G. P. Bisson,, M. J. Papania,, J. L. Heath,, D. L. Schaff,, W. J. Bellini,, S. C. Redd, and, L. J. Anderson. 1998. Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J. Med. Virol. 56:337341.
70. Helfand, R. F.,, J. L. Heath,, L. J. Anderson,, E. F. Maes,, D. Guris, and, W. J. Bellini. 1997. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J. Infect. Dis. 175:195199.
71. Henle, G.,, and F. Deinhardt. 1955. Propagation and primary isolation of mumps virus in tissue culture. Proc. Soc. Exp. Biol. Med. 89:556560.
72. Hersh, B. S.,, P. E. Fine,, W. K. Kent,, S. L. Cochi,, L. H. Kahn,, E. R. Zell,, P. L. Hays,, C. L. Wood. 1991. Mumps outbreak in highly vaccinated population. J. Pediatr. 119:187193.
73. Hopps, H. E.,, and P. D. Parkman. 1979. Mumps virus. p. 633–653. In E. H. Lennette and, N. J. Schmidt (ed.), Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections. American Public Health Association, Washington, DC.
74. Horstmann, D. M. 1991. Rubella, p. 617–631. In A. S. Evans (ed.), Viral Infections of Humans: Epidemiology and Control. Plenum Medical Book Company, New York, NY.
75. Horta-Barbosa, L.,, D. A. Fuccillo,, J. L. Sever, and, W. Zeman. 1969. Subacute sclerosing panencephalitis: isolation of measles virus from a brain biopsy. Nature 221:974.
76. Horta-Barbosa, L.,, R. Hamilton,, B. Wiltig,, D. A. Fuccillo,, J. L. Sever, and, M. L. Vernon. 1971. Subacute sclerosing panencephalitis: isolation of suppressed measles virus from lymph node biopsies. Science 173:840841.
77. Hummel, K. B.,, D. D. Erdman,, J. L. Heath, and, W. J. Bellini. 1992. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J. Clin. Microbiol. 30:28742880.
78. Hummel, K. B.,, L. Lowe,, W. J. Bellini, and, P. A. Rota. 2006. Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens. J. Virol. Methods 132:166173.
79. Hyde, T. B.,, G. H. Dayan,, J. R. Langidrik,, R. Nandy,, R. Edwards,, K. Briand,, M. Konelios,, M. Marin,, H. Nguyen,, A. P. Khalifah,, M. L. O’Leary,, N. J. Williams,, W. J. Bellini,, D. Bi,, C. J. Brown,, J. Seward, and, M. Papania. 2006. Measles outbreak in the Republic of the Marshall Islands, 2003. Int. J. Epidemiol. 35:299306.
80. Jin, L.,, D. W. G. Brown,, M. E. B. Ramsay,, P. A. Rota, and, W. J. Bellini. 1997. The diversity of measles virus in the UK, 1992–1995. J. Gen. Virol. 78:12871294.
81. Jin, L.,, S. Beard, and, D. W. Brown. 1999. Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes. J. Infect. Dis. 180:829833.
82. Jin, L.,, S. Beard,, R. Hunjan,, D. W. G. Brown, and, E. Miller. 2002. Characterization of measles virus strains causing SSPE: a study of 11 cases. J. Neurovirol. 8:335344.
83. Jin, L.,, B. Rima,, D. Brown,, C. Orvell,, T. Tecle,, M. Afzal,, K. Uchida,, T. Nakayama,, J. W. Song,, C. Kang,, P. A. Rota,, W. Xu, and, D. Featherstone. 2005. Proposal for genetic characterization of wild-type mumps strains: preliminary standardization of the nomenclature. Arch. Virol. 150:19031909.
84. Jin, L.,, and B. Thomas. 2007. Application of molecular and serological assays to case based investigations of rubella and congenital rubella syndrome. J. Med. Virol. 79:10171024.
85. Johnson, S. C.,, and E. W. Goodpasture. 1934. An investigation of the etiology of mumps. J. Exp. Med. 59:119.
86. Kashiwagi, Y.,, H. Kawashima,, K. Takekuma,, A. Hoshika,, T. Mori, and, T. Nakayama. 1997. Detection of mumps virus genome directly from clinical samples and a simple method for genetic differentiation of the Hoshino vaccine strain from wild strains of mumps virus. J. Med. Virol. 52:195199.
87. Katow, S.,, H. Minahara,, M. Fukushima, and, Y. Yamaguchi. 1997. Molecular epidemiology of rubella by nucleotide sequences of the rubella virus E1 gene in three East Asian countries. J. Infect. Dis. 176:602616.
88. Katz, R. S.,, M. Premenko-Lanier,, M. B. McChesney,, P. A. Rota, and, W. J. Bellini. 2002. Detection of measles virus RNA in whole blood stored on filter paper. J. Med. Virol. 67:596602.
89. Katz, S. L,, and A. R. Hinman. 2004. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J. Infect. Dis. 189(Suppl. 1): S43S47.
90. Kobune, F.,, H. Sakata, and, A. Sugiura. 1990. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64:700705.
91. Koplik, H. 1962. The diagnosis of the invasion of measles from a study of the exanthemata as it appears on the buccal mucus membrane. Arch. Pediatr. 13:918922.
92. Krause, C. H.,, K. Eastick, and, M. M. Ogilvie. 2006. Real-time PCR for mumps diagnosis on clinical specimens—comparison with results of conventional methods of virus detection and nested PCR. J. Clin. Virol. 37:184189.
93. Krause, C. H.,, P. J. Molyneaux,, D. O. Ho-Yen,, P. McIntyre,, W. F. Carman, and, K. E. Templeton. 2007. Comparison of mumps-IgM ELISAs in acute infection. J. Clin. Virol. 38:153156.
94. Kubar, A.,, M. Yapar,, B. Besirbellioglu,, I. Y. Avci, and, C. Guney. 2004. Rapid and quantitative detection of mumps virus RNA by one-step real-time RT-PCR. Diagn. Microbiol. Infect. Dis. 49:8388.
95. Kyaw, M. H.,, W. J. Bellini, and, G. H. Dayan. 2007. Mumps surveillance and prevention: putting mumps back on our radar screen. Cleve. Clin. J. Med. 74:1315.
96. Lamb, R. A.,, and D. Kolakofsky. 1996. Paramyxoviridae: the viruses and their replication, p. 1177–1202. In B. N. Fields,, D. M. Knipe,, P. M. Howley,, R. M. Channock,, J. L. Melnick,, T. P. Monath,, B. Roizman, and, S. E. Strauss (ed.), Fields Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, PA.
97. Lund, K. D.,, and J. K. Chantler. 2000. Mapping of genetic determinants of rubella virus associated with growth in joint tissue. J. Virol. 74:796804.
98. Markowitz, L. E.,, F. W. Chandler,, E. O. Roldan,, M. J. Saldana,, K. C. Roach,, S. S. Hutchins,, S. R. Preblud,, C. D. Mitchell, and, G. B. Scott. 1988. Fatal measles pneumonia without rash in a child with AIDS. J. Infect. Dis. 158:480483.
99. Mayo, D. R.,, T. Brennan,, D. P. Corimer,, J. Hadler, and, P. Lamb. 1991. Evaluation of a commercial measles virus immunoglobulin M enzyme immunoassay. J. Clin. Microbiol. 29:28652867.
100. Menser, M. A.,, J. M. Forrest,, M. C. Honeyman, and, J. A. Burgess. 1974. Diabetes, HLA antigens, and congenital rubella. Lancet ii:10581059.
101. Menser, M. A.,, L. Dods, and, J. D. Harley. 1967. A twenty-five year follow-up of congenital rubella. Lancet ii:13471350.
102. Minnich, L. L.,, F. Goodenough, and, C. G. Ray. 1991. Use of immunofluorescence to identify measles virus infections. J. Clin. Microbiol. 29:11481150.
103. Muhlemann, K. 2004. The molecular epidemiology of mumps virus. Infect. Genet. Evol. 4:215219.
104. Muller, C. P.,, S. Huiss, and, F. Schneider. 1996. Secondary immune response in parents of children with recent measles. Lancet 348:13791380.
105. Muller, C. P.,, J. R. Kremer,, J. M. Best,, I. Dourado,, H. Triki,, S. Reef, and the WHO Steering Committee for Measles and Rubella. 2007. Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination. Vaccine 25:19.
106. Nakayama, T.,, T. Mori,, S. Yamaguchi,, S. Sonoda,, S. Asamura,, R. Yamashita,, Y. Takeuchi, and, T. Urano. 1995. Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability. Virus Res. 35:116.
107. Narita, M.,, S. Yamada,, Y. Matsuzono,, O. Itakura,, T. Togashi, and, H. Kikuta. 1997. Measles virus-specific immunoglobulin G subclass response in serum and cerebrospinal fluid. Clin. Diagn. Virol. 8:233239.
108. Nojd, J.,, T. Tecle,, A. Samuelsson, and, C. Orvell. 2001. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 19:17271731.
109. Okafuji, T.,, N. Yoshida,, M. Fujino,, Y. Motegi,, T. Ihara,, Y. Ota,, T. Notomi, and, T. Nakayama. 2005. Rapid diagnostic method for detection of mumps virus genome by loop-mediated isothermal amplification. J. Clin. Microbiol. 43:16251631.
110. Oliveira, S. A.,, M. M. Siqueira,, L. A. Camacho,, R. Castro-Silva,, G. F. Bruno, and, B. J. Cohen. 2003 Use of RT-PCR on oral fluid samples to assist the identification of measles cases during an outbreak. Epidemiol. Infect. 130:101106.
111. Ono, N.,, H. Tatsuo,, Y. Hidaka,, T. Aoki,, H. Minagawa, and, Y. Yanagi. 2001. Measles viruses on throat swabs from measles patients use signaling-lymphocyte activation molecule (CDw150) but not CD46 as a cellular receptor. J. Virol. 75:43994401.
112. Orenstein, W. A.,, K. J. Bart,, A. R. Hinman,, S. R. Preblud,, W. L. Greaves,, S. W. Doster,, H. C. Stetler, and, B. Sirotkin. 1984. The opportunity and obligation to eliminate rubella from the United States. JAMA 251:19881994.
113. Palacios, G.,, O. Jabado,, D. Cisterna,, F. de Ory,, N. Renwick,, J. E. Echevarria,, A. Castellanos,, M. Mosquera,, M. C. Freire,, R. H. Campos, and, W. I. Lipkin. 2005. Molecular identification of mumps virus genotypes from clinical samples: standardized method of analysis. J. Clin. Microbiol. 43:18691878.
114. Pannuti, C. S.,, R. J. Morello,, J. C. Moraes,, S. P. Curti,, A. M. Afonso,, M. C. Camargo, and, V. A. Souza. 2004. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic. Clin. Diagn. Lab. Immunol. 11:119122.
115. Parker, A. A.,, W. Staggs,, G. H. Dayan,, I. R. Ortega-Sánchez,, P. A. Rota,, L. Lowe,, P. Boardman,, R. Teclaw,, C. Graves, and, C. W. LeBaron. 2006. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N. Engl. J. Med. 355:447455. (Erratum, 355:1184.)
116. Parkman, P. D.,, E. L. Buescher, and, M. S. Artenstein. 1962. Recovery of rubella virus from Army recruits. Proc. Soc. Exp. Biol. Med. 111:225230.
117. Paunio, M.,, K. Hedman,, I. Davidkin,, M. Valle,, O. P. Heinonen,, P. Leinikki,, A. Salmi, and, H. Peltola. 2000. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol. Infect. 124:263271.
118. Perry, K.,, D. Brown,, J. Parry,, S. Panday,, C. Pipkin, and, A. Richards. 1993. Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J. Med. Virol. 40:235240.
119. Philip, R. N.,, K. R. Reinhard, and, D. B. Lackman. 1959. Observations on a mumps epidemic in a “virgin” population. Am. J. Hyg. 69:91.
120. Plotkin, S. A.,, and R. Kaye. 1970. Diabetes mellitus and congenital rubella. Pediatrics 46:650651.
121. Plumet, S.,, and D. Gerlier. 2005. Optimized SYBR green realtime PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers. J. Virol. Methods 128:7987.
122. Poggio, G. P.,, C. Rodriguez,, D. Cisterna,, M. C. Freire, and, J. Cello. 2000. Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases. J. Clin. Microbiol. 38:274278.
123. Preece, M. A.,, P. J. Kearney, and, W. C. Marshall. 1977. Growth-hormone deficiency in congenital rubella. Lancet ii:842844.
124. Rakowsky, A.,, and J. L. Sever. 1998. Rubella virus, p. 2231–2234. In S. L. Gorbach,, J. G. Bartlett, and, N. R. Blacklow (ed.), Infectious Diseases. W.B. Saunders Company, Philadelphia, PA.
125. Ratnam S., V. Gadag,, R. West,, J. Burris,, E. Oates,, F. Stead, and, N. Bouilianne. 1995. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J. Clin. Microbiol. 33:811815.
126. Ratnam, S.,, G. Tipples,, C. Head,, M. Fauvel,, M. Fearon, and, B. J. Ward. 2000. Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles. J. Clin. Microbiol. 38:99104.
127. Ratzmann, K. P.,, J. Strese,, S. Witt,, H. Berling,, H. Keilacker, and, D. Michaelis. 1984. Mumps infection and insulin-dependent diabetes mellitus (IDDM). Diabetes Care 7:170173.
128. Rawls, W. E.,, and J. L. Melnick. 1966. Rubella virus carrier cultures derived from congenitally infected infants. J. Exp. Med. 123:795816.
129. Reef, S.,, and S. A. Plotkin. 2007. Rubella vaccine, p. 79–94. In J. Banatvala and, C. Peckham (ed.), Rubella Viruses, Perspectives in Medical Virology. Elsevier, Amsterdam, The Netherlands.
130. Reef, S. E.,, and S. L. Cochi. 2006a. Introduction: the evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin. Infect. Dis. 43(Suppl. 3):S123S125.
131. Reef, S. E.,, and S. L. Cochi (ed.). 2006b. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin. Infect. Dis. 43(Suppl. 3):S123S168.
132. Reina, J.,, F. Ballesteros,, E. Ruiz de Gopegui,, M. Munar, and, M. Mari. 2003. Comparison between indirect immunofluorescence assay and shell vial culture for detection of mumps virus from clinical samples. J. Clin. Microbiol. 41:51865187.
133. Rosenberg, H. S.,, E. H. Oppenheimer, and, J. R. Esterly. 1981. Congenital rubella syndrome: the late effects and their relation to early lesions. Perspect. Pediatr. Pathol. 6:183202.
134. Rota, P. A.,, A. S. Khan,, E. Durigon,, T. Yuran,, Y. S. Villamarzo, and, W. J. Bellini. 1995. Detection of measles virus RNA in urine specimens from vaccine recipients. J. Clin. Microbiol. 33:24852488.
135. Rubin, S.,, J. Mauldin,, K. Chumakov,, J. Vanderzanden,, R. Iskow, and, K. Carbone. 2006. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine 24:26622668.
136. Samuel, D.,, K. Sasnauskas,, L. Jin,, A. Gedvilaite,, R. Slibinskas,, S. Beard,, A. Zvirbliene,, S. A. Oliveira,, J. Staniulis,, B. Cohen, and, D. Brown. 2003. Development of a measles specific IgM ELISA for use with serum and oral fluid samples using recombinant measles nucleoprotein produced in Saccharomyces cerevisiae. J. Clin. Virol. 28:121129.
137. Sanz, J. C.,, M. del M. Mosquera,, J. E. Echevarría,, M. Fernández,, N. Herranz,, G. Palacios, and, F. De Ory. 2006. Sensitivity and specificity of immunoglobulin G titer for the diagnosis of mumps virus in infected patients depending on vaccination status. APMIS 114:788794.
138. Sanz-Moreno, J. C.,, A. Limia-Sanchez,, L. Garcia-Comas,, M. M. Mosquera-Gutierrez,, J. E. Echevarria-Mayo,, A. Castellanos-Nadal, and, F. de Ory-Manchon. 2005. Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G. Vaccine 23:49214925.
139. Sartorius, B.,, P. Penttinen,, J. Nilsson,, K. Johansen,, K. Jönsson,, M. Arneborn,, M. Löfdahl, and, J. Giesecke. 2005. An outbreak of mumps in Sweden, February–April 2004. Euro Surveill. 10:191193.
140. Schiff, G. M.,, and J. L. Sever. 1966. Rubella: recent laboratory and clinical advances. Prog. Med. Virol. 8:3061.
141. Schwartz, A. J. F. 1962. Preliminary tests of a highly attenuated measles vaccine. Am. J. Dis. Child. 103:386389.
142. Slibinskas, R.,, D. Samuel,, A. Gedvilaite,, J. Staniulis, and, K. Sasnauskas. 2004. Synthesis of the measles virus nucleoprotein in yeast Pichia pastoris and Saccharomyces cerevisiae. J. Biotechnol. 107:115124.
143. Smaron, M. F.,, E. Saxon,, L. Wood,, C. McCarthy, and, J. A. Morello. 1991. Diagnosis of measles by fluorescent antibody and culture of nasopharyngeal secretions. J. Virol. Methods 33:223229.
144. South, M. A.,, and C. A. Alford. 1980. The immunology of chronic intrauterine infections, p. 702–704. In R. Stiehm and, V. A. Fulginiti (ed.), Immunologic Disorders in Infants and Children, 2nd ed. W.B. Saunders, Philadelphia, PA.
145. Sultz, H.A.,, B. A. Hart,, M. Zielezny, and, E. R. Schlesinger. 1975. Is mumps virus an etiologic factor in juvenile diabetes mellitus? J. Pediatr. 86:654656.
146. Swierkosz, E. M. 1995. Mumps virus, p. 963–967. In P. R. Murray,, E. J. Baron,, M. A. Pfaller,, F. C. Tenover, and, R. H. Yolken (ed.), Manual of Clincal Microbiology, 5th ed. American Society for Microbiology, Washington, DC.
147. Thieme, T.,, S. Piacentini,, S. Davidson, and, K. Steingart. 1994. Determination of measles, mumps, and rubella immunization status using oral fluid samples. JAMA 272:219221.
148. Tipples, G. A.,, R. Hamkar,, T. Mohktari-Azad,, M. Gray,, J. Ball,, C. Head, and, S. Ratnam. 2004. Evaluation of rubella IgM enzyme immunoassays. J. Clin. Virol. 30:233238.
149. Townsend, J. J.,, W. G. Stroop,, J. R. Baringer,, J. H. Wolinsky,, J. H. McKerrow, and, B. O. Berg. 1976. Neuropathy of progressive rubella panencephalitis after childhood rubella. Neurology 32:185190.
150. Tuokko, H. 1984. Comparison of nonspecific reactivity in indirect and reverse immunoassays for measles and mumps immunoglobulin M antibodies. J. Clin. Microbiol. 20:972976.
151. Tuokko, H. 1995. Detection of acute measles infections by indirect and mu-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay. J. Med. Virol. 45:306311.
152. Uchida, K.,, M. Shinohara,, S. Shimada,, Y. Segawa,, R. Doi,, A. Gotoh, and, R. Hondo. 2005. Rapid and sensitive detection of mumps virus RNA directly from clinical samples by real-time PCR. J. Med. Virol. 75:470474.
153. Utz, J. P.,, J. A. Kasel,, H. G. Cramblett,, C. F. Szwed, and, R. H. Parrott. 1957. Clinical and laboratory studies of mumps. I. Laboratory diagnosis by tissue culture technics. N. Engl. J. Med. 257:497502.
154. Utz, J. P.,, C. F. Szwed, and, J. A. Kasel. 1958. Clinical and laboratory studies of mumps II. Detection and duration of excretion in urine. Proc. Soc. Exp. Biol. Med. 99:259261.
155. Warrener, L.,, and D. Samuel. 2006. Evaluation of a commercial assay for the detection of mumps specific IgM antibodies in oral fluid and serum specimens. J. Clin. Virol. 35:130134.
156. Watson, J. C.,, S. C. Redd,, P. H. Rhodes, and, S. C. Hadler. 1998. The interruption of transmission of indigenous measles in the United States during 1993. Pediatr. Infect. Dis. J. 17:363366.
157. Webster, W. S. 1998. Teratogen update: congenital rubella. Teratology 58:1323.
158. Weller, T. H.,, and F. A. Neva. 1962. Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc. Soc. Exp. Biol. Med. 111:215225.
159. Weller, T. H.,, C. A. Alford, and, F. A. Neva. 1964. Retrospective diagnosis by serological means of congenitally acquired rubella infection. N. Engl. J. Med. 270:10391041.
160. Whitman, C. 1999. Mumps outbreak in a highly vaccinated population. NY VAC SCENE 1[1]. The New York City Department of Health, New York, NY.
161. Wilson, R. L.,, S. M. Fuentes,, P. Wang,, E. C. Taddeo,, A. Klatt,, A. J. Henderson, and, B. He. 2006. Function of small hydrophobic proteins of paramyxovirus. J. Virol. 80:17001709.
162. Wolfson, L. J.,, P. M. Strebel,, M. Gacic-Dobo,, E. J. Hoekstra,, J. W. McFarland, and, B. S. Hersh. 2007. Measles initiative. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet 369:191200.
163. Wolinsky, J. S. 1978. Progressive rubella panencephalitis, p. 331–341. In P. J. Vinken and, G. W. Bruyn (ed.), Handbook of Clinical Neurology, vol. 34. North-Holland, Amsterdam, The Netherlands.
164. Yoshida, N.,, M. Fujino,, A. Miyata,, T. Nagai,, M. Kamada,, H. Sakiyama,, T. Ihara,, T. Kumagai,, T. Okafuji,, T. Okafuji, and, T. Nakayama. 2008. Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification. J. Med. Virol. 80:517523.
165. Zaki, S.,, and W. J. Bellini. 1997. Measles virus, p. 233–245, In D. H. Connor,, F. W. Chandler,, D. A. Schwartz,, D. J. Manz, and, E. E. Lack (ed.), Pathology of Infectious Diseases, vol 1. Appleton and Lange, Stamford, CT.
166. Zhou, Y.,, H. Ushijima, and, T. K. Frey. 2007. Genomic analysis of diverse rubella virus genotypes. J. Gen. Virol. 88:932941.
167. Zhu, Z.,, W. Xu,, E. A. Abernathy,, M.-H. Chen,, Q. Zheng,, T. Wang,, Z. Zhang,, C. Li,, C. Wang,, W. He,, S. Zhou, and, J. Icenogle. 2007. Comparison of four methods using throat swabs to confirm rubella virus infection J. Clin. Microbiol. 45:28472852.
168. Ziring, P. R.,, B. A. Fedun, and, L. A. Cooper. 1975. Thyrotoxicosis in congenital rubella. J. Pediatr. 88:1002.
169. Ziring, P. R.,, G. Gallo,, M. Finegold,, E. Buimovici-Klein, and, P. Ogra. 1977. Chronic lymphocytic thyroiditis: identification of rubella virus antigen in the thyroid of a child with congenital rubella. J. Pediatr. 90:419420.


Generic image for table

Interpretation of measles EIA results a

Citation: Bellini W, Icenogle J, Sever J. 2009. Measles, Mumps, and Rubella, p 562-577. In Specter S, Hodinka R, Young S, Wiedbrauk D (ed), Clinical Virology Manual, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815974.ch31

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error